gilead - dofaq.co
Claudiu Cheleș, Gilead România: tratamentele noastre oncologice au potențialul de a completa sau înlocui ...
HotNews.ro - 29 Nov 2023
Claudiu Cheleș, Gilead România: tratamentele noastre oncologice au potențialul de a completa sau înlocui ... ...
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution'
Fierce Pharma - 26 Apr 2024
Gilead writes $2.4B off Trodelvy as CEO underscores 'time of focused execution' ...
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
Reuters - 25 Apr 2024
Gilead posts quarterly loss on acquisition charge, revenue rises 5% ...
Gilead gives up on $4.9B antibody magrolimab
Fierce Biotech - 26 Apr 2024
Gilead gives up on $4.9B antibody magrolimab ...
Gilead Sciences: First-Quarter Results Beat Estimates
The Motley Fool - 29 Apr 2024
Gilead Sciences: First-Quarter Results Beat Estimates ...
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Clinical Trials Arena - 29 Apr 2024
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data ...
Claudiu Cheleș, Gilead Sciences Romania: Investiția în Sănătate este o resursă și o sursă de productivitate, nu o ...
Curs De Guvernare - 05 Jul 2023
Claudiu Cheleș, Gilead Sciences Romania: Investiția în Sănătate este o resursă și o sursă de productivitate, nu o ... ...
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance - 29 Apr 2024
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It ...
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
BioSpace - 26 Apr 2024
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline ...
Gilead’s quarterly loss is narrower than expected
MarketWatch - 25 Apr 2024
Gilead’s quarterly loss is narrower than expected ...
Gilead: Q1 Earnings Snapshot
Houston Chronicle - 25 Apr 2024
Gilead: Q1 Earnings Snapshot ...
PREVIEW: Gilead Sciences down more than 2%; results due after the bell
XM - 25 Apr 2024
PREVIEW: Gilead Sciences down more than 2%; results due after the bell ...
Gilead Doesn't See Big M&A In Near-Term, But Eyes Next-Gen Cell Therapies
Scrip - 25 Apr 2024
Gilead Doesn't See Big M&A In Near-Term, But Eyes Next-Gen Cell Therapies ...
Earnings call: Gilead reports robust Q1 growth, Trodelvy drives sales
Investing.com India - 29 Apr 2024
Earnings call: Gilead reports robust Q1 growth, Trodelvy drives sales ...
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo Finance - 27 Apr 2024
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags ...
Gilead posts quarterly loss on acquisition charge, revenue rises 5%
Yahoo Finance - 25 Apr 2024
Gilead posts quarterly loss on acquisition charge, revenue rises 5% ...
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
Yahoo Finance - 25 Apr 2024
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ... ...
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Yahoo Finance - 25 Apr 2024
Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say ...
Investors Purchase High Volume of Call Options on Gilead Sciences (NASDAQ:GILD)
Defense World - 30 Apr 2024
Investors Purchase High Volume of Call Options on Gilead Sciences (NASDAQ:GILD) ...